Japan’s health ministry has endorsed two stem-cell therapies derived from induced pluripotent stem (iPS) cells, making them the first treatments of their kind to clear a national regulatory body ...

Add Yahoo as a preferred source to see more of our stories on Google. Unlike typical glaucoma treatments that slow progression, this approach aims to rejuvenate the retinal ganglion cells that die ...

The US Food and Drug Administration (FDA) has approved a Phase 1 clinical trial from Life Biosciences that aims to help certain eye cells act younger and improve vision in glaucoma and related ...

During the World Economic Forum in Davos last week, Elon Musk called human aging a “very solvable” problem. “When we figure out what causes aging, I think we’ll find it’s incredibly obvious,” the ...

In a bid to treat blindness, Life Biosciences will try out potent cellular reprogramming technology on volunteers. When Elon Musk was at Davos last week, an interviewer asked him if he thought aging ...

The conversation around longevity is shifting. For decades, the goal was simple: live longer. But as medicine advances and populations age, a more nuanced question has emerged: how well can we live ...

In order to reprogram readily available cells into specific immune cells that fight various diseases, one must know the “recipe” for the transformation. Researchers at Lund University have now created ...

The year was 2021. Tech entrepreneur Micha Breakstone, PhD, had just sold the conversation intelligence platform, Chorus.ai, to ZoomInfo for $575 million and was eager for a new challenge. As an ...

Atomic defects in nanodiamonds enable both precise heating of lysosomes inside macrophages and nanoscale temperature measurement, revealing that localized thermal spikes trigger immune cell ...

New funding led by Goldcrest Capital and Godfrey Capital to advance lead candidate JUN_01 for type 2 diabetes and obesity to first-in-human studies JUN_01 would be the first ever candidate to ...